Corbion NV (0QHL)

London


	Symbol		Exchange		Currency
	CORB		Amsterdam		EUR	Real-time
	CRBNa		BATS Europe		EUR	Delayed
	CSNVY		OTC Markets		USD	Delayed
	0QHL		London		EUR	Real-time
	CSUA		Frankfurt		EUR	Delayed

Currency in EUR

Disclaimer

24.61

+0.25(+1.03%)

Closed02:35:59

Fair Value

Day's Range

24.50

25.04

52 wk Range

14.58

26.06

0QHL Income Statement

Featured here, the Income Statement (earnings report) for Corbion NV, showing the company's financial performance from operating and non operating activities such as revenue, expenses and income for the last 4 periods (either quarterly or annually).

Advanced Income Statement

Period Ending:

2014

31/12

2015

31/12

2016

31/12

2017

31/12

2018

31/12

2019

31/12

2020

31/12

2021

31/12

2022

31/12

2023

31/12

Total Revenues

976.4

986.5

1,070.8

1,457.9

1,443.8

Total Revenues Growth

+8.83%

+1.03%

+8.55%

+36.15%

-0.97%

Cost Of Revenues

669.1

710.6

801.8

1,131.5

1,112.3

Gross Profit

307.3

275.9

269

326.4

331.5

Gross Profit Growth

+19.06%

-10.22%

-2.5%

+21.34%

+1.56%

Gross Profit Margin %

31.47%

27.97%

25.12%

22.39%

22.96%

Other Operating Expenses, Total

180.9

177.1

197.2

218.4

224.3

	Other Operating Expenses, Total Growth
	R&D Expenses
	Selling General & Admin Expenses
	Other Operating Expenses

aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	+7.3%	-2.1%	+11.35%	+10.75%	+2.7%
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	34.6	37.2	42.6	47.2	46
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	146.3	139.9	154.6	171.2	178.3
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-	-	-	-	-

Operating Income

126.4

98.8

71.8

108

107.2

Operating Income Growth

+41.23%

-21.84%

-27.33%

+50.42%

-0.74%

EBIT Margin %

12.95%

10.02%

6.71%

7.41%

7.42%

Net Interest Expenses

-6.7

-9.9

-9.6

-12.4

-20.6

Net Interest Expenses Growth

-34%

-47.76%

+3.03%

-29.17%

-66.13%

Interest Expense, Total

-10.1

-12.5

-11.5

-15.8

-27

Interest And Investment Income

3.4

2.6

1.9

3.4

6.4

Other Non Operating Expenses, Total

-6.2

-6.8

14

18

-11.3

EBT, Excl. Unusual Items

113.5

82.1

76.2

113.6

75.3

Gain (Loss) On Sale Of Assets

-

-

30.2

9.5

-

Other Unusual Items, Total

-68.8

-7.3

-19.9

-6.7

10

EBT, Incl. Unusual Items

44.7

87.7

86.5

116.4

85.3

EBT, Incl. Unusual Items Growth

-35.96%

+96.2%

-1.37%

+34.57%

-26.72%

EBT, Incl. Unusual Items Margin

4.58%

8.89%

8.08%

7.98%

5.91%

Income Tax Expense

18.9

14.6

8.2

26.4

12.4

Net Income to Company

25.8

73.1

78.3

90

72.9

Minority Interest

-

-

-

-

-

Net Income

25.8

73.1

78.3

90

72.9

Net Income Growth

-52.49%

+183.33%

+7.11%

+14.94%

-19%

Net Income Margin %

2.64%

7.41%

7.31%

6.17%

5.05%

Preferred Dividend and Other Adjustments

-

-

-

-

-

Net Income to Common Excl. Extra Items

25.8

73.1

78.3

90

72.9

Basic EPS - Continuing Operations

0.44

1.24

1.33

1.53

1.23

Basic EPS - Continuing Operations Growth

-52.58%

+183.18%

+6.98%

+14.82%

-19.1%

Diluted EPS - Continuing Operations

0.43

1.23

1.32

1.51

1.22

Diluted EPS - Continuing Operations Growth

-53.26%

+186.05%

+7.32%

+14.39%

-19.21%

Basic Weighted Average Shares Outstanding

58.82

58.85

58.93

58.99

59.06

Diluted Weighted Average Shares Outstanding

59.4

59.5

59.4

59.5

59.7

Dividend Per Share

0.56

0.56

0.56

0.56

0.61

Dividend Per Share Growth

0%

0%

0%

0%

+8.93%

EBITDA

185.8

156.7

132.6

166.7

174.8

EBITDA Growth

+43.25%

-15.66%

-15.38%

+25.72%

+4.86%

EBITDA Margin %

19.03%

15.88%

12.38%

11.43%

12.11%

EBIT